Cowen Financial Products Exits Trulieve Cannabis Position
Ticker: TCNNF · Form: SC 13G/A · Filed: Feb 2, 2024 · CIK: 1754195
| Field | Detail |
|---|---|
| Company | Trulieve Cannabis Corp. (TCNNF) |
| Form Type | SC 13G/A |
| Filed Date | Feb 2, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | bearish |
Complexity: simple
Sentiment: bearish
Topics: institutional-ownership, divestment, cannabis-sector
TL;DR
**Cowen Financial Products just dumped all their Trulieve stock.**
AI Summary
Cowen Financial Products LLC filed an amended SC 13G/A on February 2, 2024, indicating a significant change in their beneficial ownership of Trulieve Cannabis Corp. common stock. As of December 29, 2023, Cowen Financial Products LLC reported owning 0 shares, a decrease from their previous holdings. This matters to investors because it signals that a major institutional investor has completely exited their position in Trulieve, potentially reflecting a change in their outlook on the company or the cannabis sector.
Why It Matters
This filing shows a major institutional investor, Cowen Financial Products LLC, has sold all its shares in Trulieve Cannabis Corp., which could be interpreted as a lack of confidence in the company's future prospects.
Risk Assessment
Risk Level: medium — The complete divestment by an institutional investor could signal underlying concerns about Trulieve's performance or the broader cannabis market, increasing risk for current shareholders.
Analyst Insight
Investors should investigate the reasons behind Cowen Financial Products LLC's complete divestment from Trulieve Cannabis Corp. and consider if these factors could impact Trulieve's future performance before making investment decisions.
Key Numbers
- 0 — Shares Beneficially Owned (Cowen Financial Products LLC's current holding in Trulieve Cannabis Corp. as of December 29, 2023, indicating a complete divestment.)
Key Players & Entities
- Cowen Financial Products LLC (company) — the reporting person who filed the SC 13G/A
- Trulieve Cannabis Corp. (company) — the subject company whose common stock is being reported
- December 29, 2023 (date) — the date of the event requiring the filing
- 0 (dollar_amount) — the aggregate amount of shares beneficially owned by Cowen Financial Products LLC
Forward-Looking Statements
- Other institutional investors may re-evaluate their positions in Trulieve Cannabis Corp. following Cowen's full divestment. (Trulieve Cannabis Corp.) — medium confidence, target: Q2 2024
FAQ
What is the purpose of this SC 13G/A filing?
This SC 13G/A filing is an amendment (Amendment No. 3) by Cowen Financial Products LLC to report a change in their beneficial ownership of Trulieve Cannabis Corp. common stock, specifically indicating a reduction in their holdings.
Who is the reporting person in this filing?
The reporting person in this filing is Cowen Financial Products LLC, with an I.R.S. Identification No. of 27-0423711 and organized in the USA.
What is the subject company of this filing?
The subject company is Trulieve Cannabis Corp., identified by CIK 0001754195, with its business address at 6749 Ben Bostic Road, Quincy, FL 32351.
What was the aggregate amount of shares beneficially owned by Cowen Financial Products LLC as of the event date?
As of December 29, 2023, Cowen Financial Products LLC reported an 'Aggregate Amount Beneficially Owned by Each Reporting Person' of 0 shares, indicating they no longer hold any shares.
Under which rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(c) of the Securities Exchange Act of 1934, as indicated by the 'X' in the appropriate box.
Filing Stats: 912 words · 4 min read · ~3 pages · Grade level 8.3 · Accepted 2024-02-02 12:43:07
Filing Documents
- tcnnfa3_20224.htm (SC 13G/A) — 25KB
- 0001085146-24-000654.txt ( ) — 27KB
(a)
ITEM 1(a). NAME OF ISSUER: Trulieve Cannabis Corp.
(b)
ITEM 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES: 6749 Ben Bostic Rd. Quincy Fla 32351
(a)
ITEM 2(a). NAME OF PERSON FILING: Cowen Financial Products LLC
(b)
ITEM 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: 599 Lexington Ave. New York, NY 10022
(c)
ITEM 2(c). CITIZENSHIP: USA
(d)
ITEM 2(d). TITLE OF CLASS OF SECURITIES: Common Stock
(e)
ITEM 2(e). CUSIP NUMBER: 89788c104 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO SECTION 240.13d-1(b), or 13d-2(b) or (c) CHECK WHETHER THE PERSON FILING IS A: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78c); (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8); (e) [ ] An investment adviser in accordance with 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with 240.13d1(b)(1)(ii)(J), please specify the type of institution: 10022 ITEM 4. (a) Amount beneficially owned: 0 (b) Percent of class: 0 (c) Number of shares as to which the person has: (i) sole power to vote or to direct the vote: Cowen Financial Products LLC : 0 (ii) shared power to vote or to direct the vote: Cowen Financial Products LLC : (iii) sole power to dispose or direct the disposition of: Cowen Financial Products LLC : 0 (iv) shared power to dispose or to direct the disposition of: Cowen Financial Products LLC : ITEM 5. If this statement is being filed to report the fact that as of the date hereof the reportin